Cerebral Edema and Neurological Recovery after Traumatic Brain Injury Are Worsened if Accompanied by a Concomitant Long Bone Fracture.
ENX
TBI
intravital microscopy
multiple trauma
tibial FX
Journal
Journal of neurotrauma
ISSN: 1557-9042
Titre abrégé: J Neurotrauma
Pays: United States
ID NLM: 8811626
Informations de publication
Date de publication:
15 02 2019
15 02 2019
Historique:
pubmed:
8
8
2018
medline:
14
7
2020
entrez:
8
8
2018
Statut:
ppublish
Résumé
Progression of severe traumatic brain injury (TBI) is associated with worsening cerebral inflammation, but it is unknown how a concomitant bone fracture (FX) affects this progression. Enoxaparin (ENX), a low molecular weight heparin often used for venous thromboembolic prophylaxis, decreases penumbral leukocyte (LEU) mobilization in isolated TBI and improves neurological recovery. We investigated if TBI accompanied by an FX worsens LEU-mediated cerebral inflammation and if ENX alters this process. CD1 male mice underwent controlled cortical impact (CCI) or sham craniotomy with or without an open tibial FX, and received either ENX (1 mg/kg, three times/day) or saline for 2 days following injury. Randomization defined four groups (Sham, CCI, CCI+FX, CCI+FX+ENX, n = 10/group). Two days after CCI, neurological recovery was assessed with the Garcia Neurological Test (GNT); intravital microscopy (LEU rolling and adhesion, microvascular leakage) and blood hemoglobin levels were also evaluated. Penumbral cerebral neutrophil sequestration (Ly-6G immunohistochemistry [IHC]) were evaluated post-mortem. In vivo LEU rolling was greater in CCI+FX (45.2 ± 4.8 LEUs/100 μm/min) than in CCI alone (26.5 ± 3.1, p = 0.007), and was suppressed by ENX (23.2 ± 5.5, p = 0.003 vs. CCI + FX). Neurovascular permeability was higher in CCI+FX (71.1 ± 2.9%) than CCI alone (42.5 ± 2.3, p < 0.001). GNT scores were lower in CCI+FX (15.2 ± 0.2) than in CCI alone (16.3 ± 0.3, p < 0.001). Hemoglobin was lowest in the CCI+FX+ENX group, lower than in Sham or CCI. IHC demonstrated greatest polymorphonuclear neutrophil (PMN) invasion in CCI+FX in uninjured cerebral territories. A concomitant long bone FX worsens TBI-induced cerebral LEU mobilization, microvascular leakage, and cerebral edema, and impairs neurological recovery at 48 h. ENX suppresses this progression but may increase bleeding.
Identifiants
pubmed: 30084745
doi: 10.1089/neu.2018.5812
pmc: PMC8349720
doi:
Substances chimiques
Anticoagulants
0
Enoxaparin
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
609-618Subventions
Organisme : NINDS NIH HHS
ID : R01 NS092398
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS094003
Pays : United States
Références
Brain Behav Immun. 2018 Mar;69:618-628
pubmed: 29355823
Annu Rev Immunol. 2011;29:139-62
pubmed: 21219181
Thromb Res. 2010 Apr;125 Suppl 2:S66-71
pubmed: 20434009
J Trauma Acute Care Surg. 2015 Jul;79(1):78-84
pubmed: 26091318
J Trauma. 2003 May;54(5 Suppl):S133-40
pubmed: 12768115
Med Res Rev. 2007 May;27(3):401-16
pubmed: 16758487
J Neuroinflammation. 2010 Jan 18;7:5
pubmed: 20082712
Scand J Immunol. 2016 Jan;83(1):26-32
pubmed: 26448486
Eur J Pharmacol. 2003 Sep 23;477(3):269-76
pubmed: 14522366
J Cereb Blood Flow Metab. 1997 Nov;17(11):1221-9
pubmed: 9390654
Arch Med Res. 2014 Nov;45(8):698-710
pubmed: 25446615
Anesthesiology. 2013 Jun;118(6):1362-72
pubmed: 23438676
J Neurotrauma. 1995 Apr;12(2):169-78
pubmed: 7629863
Brain Pathol. 2000 Jan;10(1):127-35
pubmed: 10668902
J Trauma Acute Care Surg. 2016 Dec;81(6):1088-1094
pubmed: 27533909
Injury. 2015 Apr;46(4):661-5
pubmed: 25682315
Prog Neuropsychopharmacol Biol Psychiatry. 2011 Dec 1;35(8):1846-56
pubmed: 21871519
J Clin Invest. 2002 Jul;110(1):127-36
pubmed: 12093896
J Neuroinflammation. 2016 Apr 26;13(1):90
pubmed: 27117191
Turk Neurosurg. 2011;21(2):203-9
pubmed: 21534203
Acta Neurochir Suppl. 2011;111:179-83
pubmed: 21725752
Transl Stroke Res. 2011 Dec 1;2(4):533-45
pubmed: 22350620
J Trauma Acute Care Surg. 2012 Aug;73(2):351-7; discussion 357
pubmed: 22846939
Am J Surg. 2013 Dec;206(6):840-5; discussion 845-6
pubmed: 24112683
Lancet. 2012 Sep 22;380(9847):1088-98
pubmed: 22998718
Swiss Med Wkly. 2011 Aug 29;141:w13256
pubmed: 21877298
Stroke. 1995 Apr;26(4):627-34; discussion 635
pubmed: 7709410
J Leukoc Biol. 2008 Jan;83(1):64-70
pubmed: 17884993
Trends Immunol. 2009 Nov;30(11):547-56
pubmed: 19783480
Pharmacology. 2002 May;65(1):32-7
pubmed: 11901299
Bone. 2014 May;62:79-89
pubmed: 24530870
Am J Physiol Cell Physiol. 2006 Mar;290(3):C917-24
pubmed: 16267105
CNS Drug Rev. 2002 Spring;8(1):1-30
pubmed: 12070524
Neuron. 2012 Dec 6;76(5):886-99
pubmed: 23217738
Sci Rep. 2016 Sep 29;6:34491
pubmed: 27682431
J Cereb Blood Flow Metab. 2015 Aug;35(8):1339-47
pubmed: 25853909
Brain Behav Immun. 2017 Nov;66:359-371
pubmed: 28782716
Circulation. 2010 Apr 20;121(15):1713-21
pubmed: 20368520
Nat Rev Immunol. 2007 Sep;7(9):678-89
pubmed: 17717539
Annu Rev Immunol. 2010;28:367-88
pubmed: 20192808
Nat Rev Neurosci. 2013 Feb;14(2):128-42
pubmed: 23329160
J Head Trauma Rehabil. 1999 Dec;14(6):602-15
pubmed: 10671706
J Exp Med. 2011 Dec 19;208(13):2581-90
pubmed: 22110166
J Musculoskelet Neuronal Interact. 2015 Dec;15(4):309-15
pubmed: 26636276
J Neurotrauma. 2000 Nov;17(11):1055-65
pubmed: 11101208
Curr Opin Anaesthesiol. 2011 Apr;24(2):138-43
pubmed: 21386666
Rambam Maimonides Med J. 2013 Jan 30;4(1):e0001
pubmed: 23908851